Dr. Brian Webster
Claim this profileWilmington Health
Studies Inflammatory Bowel Disease
Studies Ulcer
4 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Brian Webster is currently running
Mirikizumab
for Ulcerative Colitis
This trial is testing a medication called mirikizumab, which aims to reduce bowel urgency in adults with severe ulcerative colitis. The medication works by calming the immune system to reduce inflammation in the intestines. The study will last for several months and include multiple phases.
Recruiting2 awards Phase 3
ABX464 Maintenance Therapy
for Ulcerative Colitis
This is a multicenter, randomized study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies [corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)] and/or advanced therapies [biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors]. This study is the maintenance phase of both previous induction studies ABX464-105 and ABX464-106. All eligible subjects who have completed either one of the induction studies above mentioned, will be given the opportunity to take part in the present ABX464-107 maintenance study and will be randomized to either a double blind, placebo-controlled part (Part #1) or allocated to ABX464 50mg or 25mg open label treatment arms (Part #2) depending on their clinical response at the end of induction. This study consists of a 44-week treatment phase and a 28-days follow-up period consisting in the End of Study (EOS) visit.
Recruiting1 award Phase 3
More about Brian Webster
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Brian Webster has experience with
- ABX464
- Mirikizumab
- BT-11
- Placebo
Breakdown of trials Brian Webster has run
Inflammatory Bowel Disease
Ulcer
Ulcerative Colitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian Webster specialize in?
Brian Webster focuses on Inflammatory Bowel Disease and Ulcer. In particular, much of their work with Inflammatory Bowel Disease has involved treating patients, or patients who are undergoing treatment.
Is Brian Webster currently recruiting for clinical trials?
Yes, Brian Webster is currently recruiting for 3 clinical trials in Wilmington North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Brian Webster has studied deeply?
Yes, Brian Webster has studied treatments such as ABX464, Mirikizumab, BT-11.
What is the best way to schedule an appointment with Brian Webster?
Apply for one of the trials that Brian Webster is conducting.
What is the office address of Brian Webster?
The office of Brian Webster is located at: Wilmington Health, Wilmington, North Carolina 28401 United States. This is the address for their practice at the Wilmington Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.